Suppr超能文献

短程抗生素治疗阳性培养新生儿败血症的疗效:系统评价和荟萃分析。

Efficacy of short-course antibiotics for culture-positive neonatal sepsis: A systematic review and meta-analysis.

机构信息

Department of Neonatology, All India Institute of Medical Sciences, Rishikesh, India.

出版信息

J Paediatr Child Health. 2024 Nov;60(11):630-639. doi: 10.1111/jpc.16647. Epub 2024 Aug 16.

Abstract

Sepsis is a common cause of neonatal mortality and morbidity. Though antibiotics are the mainstay of treatment in culture-positive neonatal sepsis, the dilemma persists for the optimum duration of antimicrobial therapy. The present study aimed to evaluate the efficacy of short-course antibiotics for uncomplicated culture-positive neonatal sepsis. This systematic review and meta-analysis (PROSPERO: CRD42023444899) identified, appraised, and synthesised the available evidence from randomised and quasi-randomised controlled trials related to the efficacy of short-course (7-10 days) versus standard-course (14 days) antibiotics for uncomplicated culture-positive neonatal sepsis on the rate of treatment failure, mortality, duration of hospitalisation, morbidities including antibiotics-related adverse events, long-term neurodevelopmental outcomes and cost analysis. Data were pooled using RevMan 5.4 software. Certainty of evidence (COE) for predefined outcomes was analysed by GRADE. Available evidence showed no significant difference in the rate of treatment failure between 7- to 10-day versus 14-day antibiotics courses [risk ratio (95% confidence interval, CI), 2.45 (0.93-6.47), I = 0%, six studies, n = 573, very low COE]. No incidence of death was reported in either treatment arm in the two included studies. Duration of hospitalisation was significantly shorter with the short-course antibiotics arm compared to standard-course [mean difference (95% CI), -3.88 (-4.22 to -3.54) days, I = 0%, five studies, n = 507, low COE]. Morbidities reported in the three studies were similar. Other outcomes were not reported. To conclude the evidence is very uncertain about the effect of short-course antibiotic regimen, compared to a standard-course, on the treatment failure rate in uncomplicated culture-positive neonatal sepsis. Adequately powered trials with outcomes including death and long-term neurodevelopmental impairment are needed.

摘要

败血症是新生儿死亡和发病的常见原因。虽然抗生素是阳性培养新生儿败血症治疗的主要手段,但抗生素治疗的最佳持续时间仍然存在问题。本研究旨在评估短疗程抗生素治疗单纯阳性培养新生儿败血症的疗效。本系统评价和荟萃分析(PROSPERO:CRD42023444899)从随机和准随机对照试验中确定、评估和综合了有关单纯阳性培养新生儿败血症短疗程(7-10 天)与标准疗程(14 天)抗生素疗效的现有证据,评估指标包括治疗失败率、死亡率、住院时间、包括抗生素相关不良反应在内的并发症、长期神经发育结局以及成本分析。数据采用 RevMan 5.4 软件进行汇总。通过 GRADE 分析了预先设定结局的证据确定性(COE)。现有证据表明,7-10 天与 14 天抗生素疗程之间的治疗失败率无显著差异[风险比(95%置信区间,CI),2.45(0.93-6.47),I=0%,6 项研究,n=573,极低 COE]。两项纳入研究中,任何治疗组均未报告死亡。与标准疗程相比,短疗程抗生素组的住院时间明显缩短[平均差异(95%CI),-3.88(-4.22 至-3.54)天,I=0%,5 项研究,n=507,低 COE]。三项研究报告的并发症相似。其他结局未报告。总之,与标准疗程相比,短疗程抗生素方案对单纯阳性培养新生儿败血症的治疗失败率的影响证据非常不确定。需要进行具有包括死亡和长期神经发育损害在内的结局的充分有效的试验。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验